BioCentury
ARTICLE | Company News

Byron Biopharma, Cel-Sci deal

March 22, 2010 7:00 AM UTC

Cel-Sci granted Byron exclusive rights to commercialize Multikine in South Africa. Byron paid Cel-Sci a $125,000 licensing fee and will be responsible for obtaining regulatory approval in the territo...